با برنامه Player FM !
Breast Cancer Sessions: Highlights from SABCS 2023 with Sara Tolaney, Sarah Sammons & Paolo Tarantino
Manage episode 394995137 series 2424442
The San Antonio Breast Cancer Symposium (SABCS) 2023 took place on the 5-9th of December 2023 in San Antonio, TX. Leading experts in breast cancer came together to hear the latest clinical trial data and discuss how to improve care for patients with breast cancer.
In this podcast, we hear from Sara Tolaney, MD, MPH, Sarah Sammons, MD, and Paolo Tarantino, MD, of Dana-Farber Cancer Institute, Boston, MA, as they discuss the hot topics from SABCS 2023 in an exclusive roundtable discussion. Topics covered include updates on the management of HR+/HER2- breast cancer such as the role of CDK4/6 inhibitors as evaluated in MONARCH 3 (NCT02246621) and PARSIFAL (NCT02491983), the potential of PIK3CA described in the INAVO120 trial (NCT04191499), the use of ribociclib and endocrine therapy as adjuvant treatment in HR+/HER2- early breast cancer, and finally neoadjuvant immunotherapy in HR-positive early breast cancer.
The post Breast Cancer Sessions: Highlights from SABCS 2023 with Sara Tolaney, Sarah Sammons & Paolo Tarantino appeared first on VJOncology.
180 قسمت
Manage episode 394995137 series 2424442
The San Antonio Breast Cancer Symposium (SABCS) 2023 took place on the 5-9th of December 2023 in San Antonio, TX. Leading experts in breast cancer came together to hear the latest clinical trial data and discuss how to improve care for patients with breast cancer.
In this podcast, we hear from Sara Tolaney, MD, MPH, Sarah Sammons, MD, and Paolo Tarantino, MD, of Dana-Farber Cancer Institute, Boston, MA, as they discuss the hot topics from SABCS 2023 in an exclusive roundtable discussion. Topics covered include updates on the management of HR+/HER2- breast cancer such as the role of CDK4/6 inhibitors as evaluated in MONARCH 3 (NCT02246621) and PARSIFAL (NCT02491983), the potential of PIK3CA described in the INAVO120 trial (NCT04191499), the use of ribociclib and endocrine therapy as adjuvant treatment in HR+/HER2- early breast cancer, and finally neoadjuvant immunotherapy in HR-positive early breast cancer.
The post Breast Cancer Sessions: Highlights from SABCS 2023 with Sara Tolaney, Sarah Sammons & Paolo Tarantino appeared first on VJOncology.
180 قسمت
همه قسمت ها
×به Player FM خوش آمدید!
Player FM در سراسر وب را برای یافتن پادکست های با کیفیت اسکن می کند تا همین الان لذت ببرید. این بهترین برنامه ی پادکست است که در اندروید، آیفون و وب کار می کند. ثبت نام کنید تا اشتراک های شما در بین دستگاه های مختلف همگام سازی شود.